title: Long-term experience of spironolactone in essential hypertension.
authors.affiliation: Service d'Hypertension Artérielle, Hôpital Broussais, Paris, France.
authors.forename: X
authors.initials: X
authors.lastname: Jeunemaitre
authors.forename: C
authors.initials: C
authors.lastname: Kreft-Jais
authors.forename: G
authors.initials: G
authors.lastname: Chatellier
authors.forename: J
authors.initials: J
authors.lastname: Julien
authors.forename: P
authors.initials: P
authors.lastname: Degoulet
authors.forename: P F
authors.initials: PF
authors.lastname: Plouin
authors.forename: J
authors.initials: J
authors.lastname: Ménard
authors.forename: P
authors.initials: P
authors.lastname: Corvol
mesh_terms: D001794:Blood Pressure / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006177:Gynecomastia / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013148:Spironolactone / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D013148:Spironolactone